Long Term Outcomes of First Line Tyrosine Kinase Inhibitors for Chronic Phase Chronic Myeloid Leukemia: A Mixed-Treatment Comparison

被引：0
|
作者：
Firwana, Belal [1 ]
Sonbol, Mohamad Bassam [2 ]
Diab, Maria [3 ]
Hasan, Rim [1 ]
Yousef, Ibraheem [1 ]
Garipalli, Archana [1 ]
Raza, Shahzad [4 ]
Al-Kali, Aref [5 ]
Doll, Donald [4 ]
机构：
[1] Univ Missouri, Columbia, MO USA
[2] Georgia Regents Univ, Augusta, GA USA
[3] Wayne State Univ, Detroit, MI USA
[4] Univ Missouri, Columbia, MO USA
[5] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Diab, Maria
    Raza, Shahzad
    Hasan, Rim
    Yousef, Ibrahim
    Zarzour, Ahmad
    Garipalli, Archana
    Doll, Donald
    Murad, M. Hassan
    Al-Kali, Aref
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (06) : 1545 - 1553
  • [2] Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison.
    Firwana, Belal
    Diab, Maria
    Sonbol, Mohamad Bassam
    Yousef, Ibraheem
    Hasan, Rim
    Raza, Shahzad
    Doll, Donald C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
    Guilhot, Francois
    Hehlmann, Ruediger
    BLOOD, 2025, 145 (09)
  • [4] Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia A Review of Tyrosine Kinase Inhibitors
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2011, 117 (05) : 897 - 906
  • [5] Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia
    Kong, Jee Hyun
    Winton, Elliott F.
    Heffner, Leonard
    Gaddh, Manila
    Hill, Brittany
    Arellano, Martha
    El-Rassi, Fuad
    Kim, Audrey
    Jillella, Anand
    Kota, Vamsi K.
    BLOOD, 2017, 130
  • [6] Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors
    Kong, Jee Hyun
    Winton, Elliott F.
    Heffner, Leonard T.
    Gaddh, Manila
    Hill, Brittany
    Neely, Jessica
    Hatcher, Angela
    Joseph, Meena
    Arellano, Martha
    El-Rassi, Fuad
    Kim, Audrey
    Khoury, Jean Hanna
    Kota, Vamsi K.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [7] Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience
    Chitanava, Tamara
    Matvienko, Iuliia
    Shuvaev, Vasily
    Voloshin, Sergey
    Martynkevich, Irina
    Vlasova, Yulia
    Efremova, Elizaveta
    Mileeva, Ekaterina
    Pirkhalo, Anna
    Makarova, Taiana
    Vlasik, Roman
    Karyagina, Elena
    Ilina, Natalia
    Medvedeva, Nadezhda
    Dorofeeva, Natalia
    Shneider, Tatiana
    Siordiya, Nadia
    Kulemina, Olga
    Sbityakova, Evgenia
    Lazorko, Natalia
    Alexeeva, Julia
    Motorin, Dmitrii
    Morozova, Elena
    Lomaia, Elza
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
    Tolomeo, Manlio
    Dieli, Francesco
    Gebbia, Nicola
    Simoni, Daniele
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 853 - 863
  • [9] Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia
    Lomaia, Elza
    Zaritskey, Andrey
    Shuvaev, Vasily
    Martynkevich, Irina
    Fominykh, Mikhail
    Ovsyannikova, Ekaterina
    Lazorko, Natalia
    Matyuhina, Natalia
    Butylin, Pavel
    Machyulaitene, Elena
    Salamatova, Evgenia
    Abdulkadyrov, Kudrat
    BLOOD, 2015, 126 (23)
  • [10] The Role of the Newer Tyrosine Kinase Inhibitors As First Line Treatment in Chronic Phase Chronic Myeloid Leukemia - an Updated Meta-Analysis
    Gurion, Ronit
    Vidal, Liat
    Leader, Avi
    Raanani, Pia
    Gafter-Gvili, Anat
    BLOOD, 2014, 124 (21)
12345